Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion
| Autor: | Gregory P. Forlenza, Carol J. Levy, Rodolfo J. Galindo, Janet B. McGill, Guillermo E. Umpierrez, Anders L. Carlson, Christopher G. Parkin, Grazia Aleppo, Davida F. Kruger |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Insulin pump
medicine.medical_specialty Endocrinology Diabetes and Metabolism PLGS Insurance coverage 030209 endocrinology & metabolism Type 2 diabetes Medicare 03 medical and health sciences Insulin Infusion Systems 0302 clinical medicine Endocrinology Diabetes mellitus AID medicine Humans Hypoglycemic Agents Insulin 030212 general & internal medicine Intensive care medicine health care economics and organizations Aged Type 1 diabetes Centers for Medicare & Medicaid Services business.industry CSII LGS HCL medicine.disease United States Subcutaneous insulin Medical Laboratory Technology Diabetes Mellitus Type 2 Commentary Clinical value business |
| Zdroj: | Diabetes Technology & Therapeutics |
| ISSN: | 1557-8593 1520-9156 |
| DOI: | 10.1089/dia.2021.0196 |
| Popis: | Numerous studies have demonstrated the clinical value and safety of insulin pump therapy in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for insulin pump coverage required by the Centers for Medicare & Medicaid Services (CMS) discount conclusive evidence that supports insulin pump use in diabetes populations that are currently deemed ineligible. This article discusses the limitations and inconsistencies of the insulin pump eligibility criteria relative to current scientific evidence and proposes workable solutions to address this issue and improve the safety and care of all individuals with diabetes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|